Issue link:

Contents of this Issue


Page 6 of 31

Dear Readers: In this issue of Inhalation, we are happy to present articles on the following topics and hope you will find them enjoyable and thought-provoking: • Nasal and trans-nasal lung deposition of aerosols • Point of view: Overcoming barriers to affordabil- ity of orally inhaled products while protecting innovation • Back page: Inhaler digital sensors help correlate reductions in power plant emissions and improve- ments in asthma • Cross-industry organizations: e Aerosol Society and Drug Delivery to the Lungs 2020 As the world continues to fight COVID-19 and takes first steps toward reopening, we are encouraged by the tremendous response from the pharmaceutical industry, including multiple initiatives from the inhalation community. Some of our readers are on the front lines, working in hospitals directly with COVID-19 patients. Com- panies are donating personal protective equipment and making financial contributions to community food and healthcare support groups. Others have piv- oted to manufacture face shields and hand sanitizer. Businesses have found creative ways to stay open and support customers while practicing social distancing. Companies have made commitments to provide test- ing, clinical research and manufacturing services for desperately needed vaccine and therapy candidates. In academia, scientists are pursuing new research while consultants provide key support. Conference organizers who produce events that we all enjoy for learning and camaraderie are finding new ways to present and share information. And thousands of peo- ple have worked from home to flatten disease curves and care for children who temporarily cannot attend school. At the same time, the inhalation community continues to support patients who have asthma, COPD and other diseases. We are gratified by all of these and look forward to times when we can gather together again, in person and safely. We send our best wishes to you and your coworkers and families. Vicki L. Schuman Editor, Inhalation BREATHE EASY RECIPHARM INHALATION SOLUTIONS ™ Simplify inhalable drug product development and manage complexity along the journey to commercialisation. One partner, one solution to take you seamlessly from development to market. Find out more at

Articles in this issue

Links on this page

view archives of Inhalation - INH0620